APA

de Galan B. E., Zoungas S., Chalmers J., Anderson C., Dufouil C., Pillai A., Cooper M., Grobbee D. E., Hackett M., Hamet P., Heller S. R., Lisheng L., MacMahon S., Mancia G., Neal B., Pan C. Y., Patel A., Poulter N., Travert F. & Woodward M. (20100426). Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. : Diabetologia.

Chicago

de Galan B E, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee D E, Hackett M, Hamet P, Heller S R, Lisheng L, MacMahon S, Mancia G, Neal B, Pan C Y, Patel A, Poulter N, Travert F and Woodward M. 20100426. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. : Diabetologia.

Harvard

de Galan B. E., Zoungas S., Chalmers J., Anderson C., Dufouil C., Pillai A., Cooper M., Grobbee D. E., Hackett M., Hamet P., Heller S. R., Lisheng L., MacMahon S., Mancia G., Neal B., Pan C. Y., Patel A., Poulter N., Travert F. and Woodward M. (20100426). Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. : Diabetologia.

MLA

de Galan B E, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee D E, Hackett M, Hamet P, Heller S R, Lisheng L, MacMahon S, Mancia G, Neal B, Pan C Y, Patel A, Poulter N, Travert F and Woodward M. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. : Diabetologia. 20100426.